• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Drug Class
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Route of Administration
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global chronic kidney disease (CKD) drugs market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global chronic kidney disease (ckd) drugs market 2018 – 2022 ($ billion)
o 4.2 Drug Class Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Drug Class Segment 2018 – 2022 ($ billion)
o 4.3 Route of Administration Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Route of Administration Segment 2018 – 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Drug Class
o 6.1 Market segments
o Exhibit 30: Chart on Drug Class – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Drug Class – Market share 2023-2028 (%)
o 6.2 Comparison by Drug Class
o Exhibit 32: Chart on Comparison by Drug Class
o Exhibit 33: Data Table on Comparison by Drug Class
o 6.3 Erythropoietin stimulating agents (ESAs) – Market size and forecast 2023-2028
o Exhibit 34: Chart on Erythropoietin stimulating agents (ESAs) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Erythropoietin stimulating agents (ESAs) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Erythropoietin stimulating agents (ESAs) – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Erythropoietin stimulating agents (ESAs) – Year-over-year growth 2023-2028 (%)
o 6.4 Calcium channel blockers – Market size and forecast 2023-2028
o Exhibit 38: Chart on Calcium channel blockers – Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Calcium channel blockers – Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Calcium channel blockers – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Calcium channel blockers – Year-over-year growth 2023-2028 (%)
o 6.5 Phosphate binders – Market size and forecast 2023-2028
o Exhibit 42: Chart on Phosphate binders – Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on Phosphate binders – Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on Phosphate binders – Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Phosphate binders – Year-over-year growth 2023-2028 (%)
o 6.6 ACE inhibitors – Market size and forecast 2023-2028
o Exhibit 46: Chart on ACE inhibitors – Market size and forecast 2023-2028 ($ billion)
o Exhibit 47: Data Table on ACE inhibitors – Market size and forecast 2023-2028 ($ billion)
o Exhibit 48: Chart on ACE inhibitors – Year-over-year growth 2023-2028 (%)
o Exhibit 49: Data Table on ACE inhibitors – Year-over-year growth 2023-2028 (%)
o 6.7 Others – Market size and forecast 2023-2028
o Exhibit 50: Chart on Others – Market size and forecast 2023-2028 ($ billion)
o Exhibit 51: Data Table on Others – Market size and forecast 2023-2028 ($ billion)
o Exhibit 52: Chart on Others – Year-over-year growth 2023-2028 (%)
o Exhibit 53: Data Table on Others – Year-over-year growth 2023-2028 (%)
o 6.8 Market opportunity by Drug Class
o Exhibit 54: Market opportunity by Drug Class ($ billion)
o Exhibit 55: Data Table on Market opportunity by Drug Class ($ billion)
• 7 Market Segmentation by Route of Administration
o 7.1 Market segments
o Exhibit 56: Chart on Route of Administration – Market share 2023-2028 (%)
o Exhibit 57: Data Table on Route of Administration – Market share 2023-2028 (%)
o 7.2 Comparison by Route of Administration
o Exhibit 58: Chart on Comparison by Route of Administration
o Exhibit 59: Data Table on Comparison by Route of Administration
o 7.3 Oral – Market size and forecast 2023-2028
o Exhibit 60: Chart on Oral – Market size and forecast 2023-2028 ($ billion)
o Exhibit 61: Data Table on Oral – Market size and forecast 2023-2028 ($ billion)
o Exhibit 62: Chart on Oral – Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Oral – Year-over-year growth 2023-2028 (%)
o 7.4 Subcutaneous – Market size and forecast 2023-2028
o Exhibit 64: Chart on Subcutaneous – Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Data Table on Subcutaneous – Market size and forecast 2023-2028 ($ billion)
o Exhibit 66: Chart on Subcutaneous – Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on Subcutaneous – Year-over-year growth 2023-2028 (%)
o 7.5 Intravenous – Market size and forecast 2023-2028
o Exhibit 68: Chart on Intravenous – Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Data Table on Intravenous – Market size and forecast 2023-2028 ($ billion)
o Exhibit 70: Chart on Intravenous – Year-over-year growth 2023-2028 (%)
o Exhibit 71: Data Table on Intravenous – Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Route of Administration
o Exhibit 72: Market opportunity by Route of Administration ($ billion)
o Exhibit 73: Data Table on Market opportunity by Route of Administration ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 75: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 77: Chart on Geographic comparison
o Exhibit 78: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 79: Chart on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 83: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 87: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 91: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 95: Chart on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 China – Market size and forecast 2023-2028
o Exhibit 99: Chart on China – Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on China – Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.9 Germany – Market size and forecast 2023-2028
o Exhibit 103: Chart on Germany – Market size and forecast 2023-2028 ($ billion)
o Exhibit 104: Data Table on Germany – Market size and forecast 2023-2028 ($ billion)
o Exhibit 105: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.10 UK – Market size and forecast 2023-2028
o Exhibit 107: Chart on UK – Market size and forecast 2023-2028 ($ billion)
o Exhibit 108: Data Table on UK – Market size and forecast 2023-2028 ($ billion)
o Exhibit 109: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.11 India – Market size and forecast 2023-2028
o Exhibit 111: Chart on India – Market size and forecast 2023-2028 ($ billion)
o Exhibit 112: Data Table on India – Market size and forecast 2023-2028 ($ billion)
o Exhibit 113: Chart on India – Year-over-year growth 2023-2028 (%)
o Exhibit 114: Data Table on India – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 115: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 117: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 119: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 120: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 121: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 122: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 123: Abbott Laboratories – Overview
o Exhibit 124: Abbott Laboratories – Business segments
o Exhibit 125: Abbott Laboratories – Key news
o Exhibit 126: Abbott Laboratories – Key offerings
o Exhibit 127: Abbott Laboratories – Segment focus
o 12.4 AbbVie Inc.
o Exhibit 128: AbbVie Inc. – Overview
o Exhibit 129: AbbVie Inc. – Product / Service
o Exhibit 130: AbbVie Inc. – Key news
o Exhibit 131: AbbVie Inc. – Key offerings
o 12.5 Amgen Inc.
o Exhibit 132: Amgen Inc. – Overview
o Exhibit 133: Amgen Inc. – Product / Service
o Exhibit 134: Amgen Inc. – Key offerings
o 12.6 AstraZeneca Plc
o Exhibit 135: AstraZeneca Plc – Overview
o Exhibit 136: AstraZeneca Plc – Product / Service
o Exhibit 137: AstraZeneca Plc – Key news
o Exhibit 138: AstraZeneca Plc – Key offerings
o 12.7 Bayer AG
o Exhibit 139: Bayer AG – Overview
o Exhibit 140: Bayer AG – Business segments
o Exhibit 141: Bayer AG – Key news
o Exhibit 142: Bayer AG – Key offerings
o Exhibit 143: Bayer AG – Segment focus
o 12.8 Biogen Inc.
o Exhibit 144: Biogen Inc. – Overview
o Exhibit 145: Biogen Inc. – Product / Service
o Exhibit 146: Biogen Inc. – Key offerings
o 12.9 Boehringer Ingelheim International GmbH
o Exhibit 147: Boehringer Ingelheim International GmbH – Overview
o Exhibit 148: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 149: Boehringer Ingelheim International GmbH – Key news
o Exhibit 150: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 151: Boehringer Ingelheim International GmbH – Segment focus
o 12.10 Eli Lilly and Co.
o Exhibit 152: Eli Lilly and Co. – Overview
o Exhibit 153: Eli Lilly and Co. – Product / Service
o Exhibit 154: Eli Lilly and Co. – Key news
o Exhibit 155: Eli Lilly and Co. – Key offerings
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 156: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 157: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 158: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 159: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 160: F. Hoffmann La Roche Ltd. – Segment focus
o 12.12 Horizon Therapeutics Plc
o Exhibit 161: Horizon Therapeutics Plc – Overview
o Exhibit 162: Horizon Therapeutics Plc – Business segments
o Exhibit 163: Horizon Therapeutics Plc – Key news
o Exhibit 164: Horizon Therapeutics Plc – Key offerings
o Exhibit 165: Horizon Therapeutics Plc – Segment focus
o 12.13 Johnson and Johnson
o Exhibit 166: Johnson and Johnson – Overview
o Exhibit 167: Johnson and Johnson – Business segments
o Exhibit 168: Johnson and Johnson – Key news
o Exhibit 169: Johnson and Johnson – Key offerings
o Exhibit 170: Johnson and Johnson – Segment focus
o 12.14 Novartis AG
o Exhibit 171: Novartis AG – Overview
o Exhibit 172: Novartis AG – Business segments
o Exhibit 173: Novartis AG – Key offerings
o Exhibit 174: Novartis AG – Segment focus
o 12.15 OPKO Health Inc.
o Exhibit 175: OPKO Health Inc. – Overview
o Exhibit 176: OPKO Health Inc. – Business segments
o Exhibit 177: OPKO Health Inc. – Key offerings
o Exhibit 178: OPKO Health Inc. – Segment focus
o 12.16 Pfizer Inc.
o Exhibit 179: Pfizer Inc. – Overview
o Exhibit 180: Pfizer Inc. – Product / Service
o Exhibit 181: Pfizer Inc. – Key news
o Exhibit 182: Pfizer Inc. – Key offerings
o 12.17 Sanofi SA
o Exhibit 183: Sanofi SA – Overview
o Exhibit 184: Sanofi SA – Business segments
o Exhibit 185: Sanofi SA – Key news
o Exhibit 186: Sanofi SA – Key offerings
o Exhibit 187: Sanofi SA – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 188: Inclusions checklist
o Exhibit 189: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 190: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 191: Research methodology
o Exhibit 192: Validation techniques employed for market sizing
o Exhibit 193: Information sources
o 13.5 List of abbreviations
o Exhibit 194: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary – Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global chronic kidney disease (ckd) drugs market 2018 – 2022 ($ billion)
Exhibits19: Historic Market Size – Drug Class Segment 2018 – 2022 ($ billion)
Exhibits20: Historic Market Size – Route of Administration Segment 2018 – 2022 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Drug Class – Market share 2023-2028 (%)
Exhibits31: Data Table on Drug Class – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Drug Class
Exhibits33: Data Table on Comparison by Drug Class
Exhibits34: Chart on Erythropoietin stimulating agents (ESAs) – Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Erythropoietin stimulating agents (ESAs) – Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Erythropoietin stimulating agents (ESAs) – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Erythropoietin stimulating agents (ESAs) – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Calcium channel blockers – Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Calcium channel blockers – Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Calcium channel blockers – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Calcium channel blockers – Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Phosphate binders – Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Phosphate binders – Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Phosphate binders – Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Phosphate binders – Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on ACE inhibitors – Market size and forecast 2023-2028 ($ billion)
Exhibits47: Data Table on ACE inhibitors – Market size and forecast 2023-2028 ($ billion)
Exhibits48: Chart on ACE inhibitors – Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on ACE inhibitors – Year-over-year growth 2023-2028 (%)
Exhibits50: Chart on Others – Market size and forecast 2023-2028 ($ billion)
Exhibits51: Data Table on Others – Market size and forecast 2023-2028 ($ billion)
Exhibits52: Chart on Others – Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Others – Year-over-year growth 2023-2028 (%)
Exhibits54: Market opportunity by Drug Class ($ billion)
Exhibits55: Data Table on Market opportunity by Drug Class ($ billion)
Exhibits56: Chart on Route of Administration – Market share 2023-2028 (%)
Exhibits57: Data Table on Route of Administration – Market share 2023-2028 (%)
Exhibits58: Chart on Comparison by Route of Administration
Exhibits59: Data Table on Comparison by Route of Administration
Exhibits60: Chart on Oral – Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Oral – Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Oral – Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Oral – Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Subcutaneous – Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on Subcutaneous – Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on Subcutaneous – Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Subcutaneous – Year-over-year growth 2023-2028 (%)
Exhibits68: Chart on Intravenous – Market size and forecast 2023-2028 ($ billion)
Exhibits69: Data Table on Intravenous – Market size and forecast 2023-2028 ($ billion)
Exhibits70: Chart on Intravenous – Year-over-year growth 2023-2028 (%)
Exhibits71: Data Table on Intravenous – Year-over-year growth 2023-2028 (%)
Exhibits72: Market opportunity by Route of Administration ($ billion)
Exhibits73: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on US – Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on US – Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on China – Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on China – Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Germany – Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on Germany – Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on UK – Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on UK – Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits111: Chart on India – Market size and forecast 2023-2028 ($ billion)
Exhibits112: Data Table on India – Market size and forecast 2023-2028 ($ billion)
Exhibits113: Chart on India – Year-over-year growth 2023-2028 (%)
Exhibits114: Data Table on India – Year-over-year growth 2023-2028 (%)
Exhibits115: Market opportunity By Geographical Landscape ($ billion)
Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits117: Impact of drivers and challenges in 2023 and 2028
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: Abbott Laboratories – Overview
Exhibits124: Abbott Laboratories – Business segments
Exhibits125: Abbott Laboratories – Key news
Exhibits126: Abbott Laboratories – Key offerings
Exhibits127: Abbott Laboratories – Segment focus
Exhibits128: AbbVie Inc. – Overview
Exhibits129: AbbVie Inc. – Product / Service
Exhibits130: AbbVie Inc. – Key news
Exhibits131: AbbVie Inc. – Key offerings
Exhibits132: Amgen Inc. – Overview
Exhibits133: Amgen Inc. – Product / Service
Exhibits134: Amgen Inc. – Key offerings
Exhibits135: AstraZeneca Plc – Overview
Exhibits136: AstraZeneca Plc – Product / Service
Exhibits137: AstraZeneca Plc – Key news
Exhibits138: AstraZeneca Plc – Key offerings
Exhibits139: Bayer AG – Overview
Exhibits140: Bayer AG – Business segments
Exhibits141: Bayer AG – Key news
Exhibits142: Bayer AG – Key offerings
Exhibits143: Bayer AG – Segment focus
Exhibits144: Biogen Inc. – Overview
Exhibits145: Biogen Inc. – Product / Service
Exhibits146: Biogen Inc. – Key offerings
Exhibits147: Boehringer Ingelheim International GmbH – Overview
Exhibits148: Boehringer Ingelheim International GmbH – Business segments
Exhibits149: Boehringer Ingelheim International GmbH – Key news
Exhibits150: Boehringer Ingelheim International GmbH – Key offerings
Exhibits151: Boehringer Ingelheim International GmbH – Segment focus
Exhibits152: Eli Lilly and Co. – Overview
Exhibits153: Eli Lilly and Co. – Product / Service
Exhibits154: Eli Lilly and Co. – Key news
Exhibits155: Eli Lilly and Co. – Key offerings
Exhibits156: F. Hoffmann La Roche Ltd. – Overview
Exhibits157: F. Hoffmann La Roche Ltd. – Business segments
Exhibits158: F. Hoffmann La Roche Ltd. – Key news
Exhibits159: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits160: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits161: Horizon Therapeutics Plc – Overview
Exhibits162: Horizon Therapeutics Plc – Business segments
Exhibits163: Horizon Therapeutics Plc – Key news
Exhibits164: Horizon Therapeutics Plc – Key offerings
Exhibits165: Horizon Therapeutics Plc – Segment focus
Exhibits166: Johnson and Johnson – Overview
Exhibits167: Johnson and Johnson – Business segments
Exhibits168: Johnson and Johnson – Key news
Exhibits169: Johnson and Johnson – Key offerings
Exhibits170: Johnson and Johnson – Segment focus
Exhibits171: Novartis AG – Overview
Exhibits172: Novartis AG – Business segments
Exhibits173: Novartis AG – Key offerings
Exhibits174: Novartis AG – Segment focus
Exhibits175: OPKO Health Inc. – Overview
Exhibits176: OPKO Health Inc. – Business segments
Exhibits177: OPKO Health Inc. – Key offerings
Exhibits178: OPKO Health Inc. – Segment focus
Exhibits179: Pfizer Inc. – Overview
Exhibits180: Pfizer Inc. – Product / Service
Exhibits181: Pfizer Inc. – Key news
Exhibits182: Pfizer Inc. – Key offerings
Exhibits183: Sanofi SA – Overview
Exhibits184: Sanofi SA – Business segments
Exhibits185: Sanofi SA – Key news
Exhibits186: Sanofi SA – Key offerings
Exhibits187: Sanofi SA – Segment focus
Exhibits188: Inclusions checklist
Exhibits189: Exclusions checklist
Exhibits190: Currency conversion rates for US$
Exhibits191: Research methodology
Exhibits192: Validation techniques employed for market sizing
Exhibits193: Information sources
Exhibits194: List of abbreviations